Rodolfo Delfini Cançado is an expert in Hematology at Hospital Samaritano de São Paulo (Brazil). As of July 2026, ScienceLeadR ranks Rodolfo Delfini Cançado in the top 1% of experts worldwide for Anemia, and in the top 1% of experts in Brazil for Iron Metabolism Disorders. Rodolfo Delfini Cançado has authored 136 publications, the most recent in 2026. SLR score: 408 (community average: 125). How the SLR is computed.

LeadR Profile

Rodolfo Delfini Cançado, PhD Hospital Samaritano de São Paulo Brazil
408 ScienceLeadR Reputation 408
Network Map

Hematology

Subspecialties: Biochemistry - Genetics - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Faculdade de Ciências Médicas da Santa Casa de São Paulo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 136

Citations

Citations: 2 554 1st author: 37 Last author: 24 Unique author: 13


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence.
PMID 42048947 — travel, focus groups, hemoglobinuria, therapeutics
Hematol Transfus Cell Ther20260
Risk of vaso-occlusive crisis requiring hospitalization in sickle cell disease patients in brazil: retrospective cohort study of real-world data.
PMID 41711948 — cells, hematology, hospitalization, anemia, sickle cell, cohort studies, hematologic diseases, vaso-occlusive crises
Ann Hematol20260
Drug development for sickle cell disease: repeated setbacks, yet there remains an optimistic outlook for future breakthroughs.
PMID 41520455 — cells, drug development, anemia, sickle cell, pharmaceutical preparations
Hematol Transfus Cell Ther20260
Hematological ratios and cytokine profiles in heterozygous beta-thalassemia.
PMID 40367897 — cytokines, beta-thalassemia, lymphocytes, anemia, neutrophils, thalassemia, globins, blood platelets
Hematol Transfus Cell Ther20253
Optimization of hydroxyurea in sickle cell disease in Brazil.
PMID 40315754 — cells, anemia, sickle cell, tablets, therapeutics, hydroxyurea
Hematol Transfus Cell Ther20250

LeadR Networks

Main global connection map